Replies to post #111 on AMAG Pharmaceuticals (AMAG)

[Monroe1]

Today Reuters News on AMAG to sell Vyleesi for $899 is intentionally conglomerated and misleading with ADDYI by BNC corp.

I've noticed a lot of PR's in the pharmaceutical world as quite prejudiced toward the existing Big Pharma when competition is on the horizon of being introduced. As well the analysts really bend toward the existing brands.


Amag's female libido injectable therapy to sell at $899
BY Reuters
— 12:21 PM ET 08/06/2019

By Saumya Joseph

Aug 6 (Reuters) - Amag Pharmaceuticals Inc's ( AMAG

) treatment to boost sexual desire in premenopausal women will be offered at $899 and is the only injectable drug on the market for the condition.

The therapy, Vyleesi, was approved in June and will be available in September through the company's specialty pharmacy distribution network that would deliver the treatment to patients' homes.